Business Wire

Gas Storage Denmark: Call for Interest

12.7.2023 13:42:00 EEST | Business Wire | Press release

Share

With its CO2RYLUS project Gas Storage Denmark A/S (GSD) intends to establish onshore CO2 storage at the Stenlille facility – and expects to offer both injection and storage capacity for CO2 from ultimo 2025. The rate of expansion of GSD’s CO2 capacities will depend on customer demand. GSD would therefore appreciate feedback from potential customers with regards to such storage needs.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230712819960/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Stenlille facility in Denmark onshore CO2 storage (Photo: Business Wire)

Companies with an interest in storing CO2 at Stenlille are therefore encouraged to write to co2rylus@gasstorage.dk to inform GSD about their interest. All inquiries will be treated with confidentiality. GSD expects to be open for input from market actors until at least the 15th of August 2023.

About the CO2RYLUS project

The CO2-project in Stenlille is known under the name CO2RYLUS. Based on continuous investigation of the reservoir the expectations to the storage capacity is a minimum of 10 million tons of CO2.

Gas Storage Denmark has 30+ years of experience with underground storage in Stenlille due to the existing methane gas storage facility. Thus, GSD has extensive knowledge of the underground and thorough practical experience with safety and monitoring.

Since the beginning of operations in Stenlille GSD has maintained good relations with neighbors, local stakeholders and communities through active dialogue and transparency regarding plans for development.

Further, the existing infrastructure and organization enables a relatively fast establishment of large-scale CO2-storage in Stenlille.

Finally, an important factor in establishing a CO2 storage adjacent to the existing methane storage operation in Stenlille is the acceleration factor. With this project, Gas Storage Denmark seek to actively work together with the partners in the industry to reduce risks, optimize setup and improve the timelines for CCS projects in Denmark in general.

The CO2RYLUS project intends to create a platform for innovation and acceleration of the CCS technology in Denmark. The platform will be used to disseminate and share technical reservoir knowledge as well as experience with early industry standards in the integrated value chain “from chimney to underground” to promote accelerated development of the industry.

Specifically for this purpose Gas Storage Denmark is hosting and contributing actively to several research projects in collaboration with universities and others.

For further information and/or a show of interest please contact us at: co2rylus@gasstorage.dk

Find the Co2rylus project at: www.gasstorage.dk/co2-storage

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Ann Marker
co2rylus@gasstorage.dk

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Align Partners Issues Public Shareholder Letter and Submits Formal Shareholder Proposals to DB Insurance9.2.2026 16:26:00 EET | Press release

Align Partners Capital Management Inc. (“Align Partners”), a shareholder of DB Insurance Co., Ltd. (KRX:005830) (“DBI” or the “Company”) holding 1.9%, has issued a public shareholder letter to DBI’s Board of Directors aimed at strengthening capital allocation policy and governance oversight, and submitted formal shareholder proposals for the 2026 Annual General Meeting (“AGM”). Despite DBI’s robust fundamentals—including a 16.1% ROE and a 226% K-ICS ratio—the Company trades at an adjusted PBR of 0.40x, representing a severe 60% discount to its Comprehensive Equity under IFRS17. Align Partners identifies inefficient capital allocation and a lack of independent governance oversight as primary drivers of this persistent undervaluation. The letter notes that DBI’s Return on Required Capital (ROR) of 21.2% significantly lags behind domestic and global peers, reflecting a historical focus on top-line growth over risk-adjusted profitability. This is exacerbated by a passive payout policy and

Promega Unveils Cellular Target Engagement Technology Aimed at Expanding the Druggable Proteome at SLAS 20269.2.2026 14:00:00 EET | Press release

Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate proteins. The TarSeer™ BRETSA™ Target Engagement System is a novel bioluminescence resonance energy transfer-based shift assay for detecting ligand-protein interactions in intact cells using protein denaturation. It gives drug discovery researchers early, target-specific cellular insights by validating weak or early chemical matter and expanding the targets accessible in live-cell drug discovery workflows. The technology will be debuted at the Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition in Boston, February 7-11, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260206015371/en/ “You can now potentially study intracellular target engagement for any protein in live cells,” says M

Eurofins Viracor BioPharma Expands Bioanalytical Capabilities9.2.2026 14:00:00 EET | Press release

Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers and molecular assays, announces a significant expansion of its service portfolio with the addition of enhanced bioanalytical testing capabilities. These new services are fully aligned with Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), enabling the company to enhance support of biopharmaceutical development programs with greater scientific breadth throughout the drug development workflow. This strategic advancement follows the successful relocation and integration of Eurofins Pharma Bioanalytics Services from St. Charles, Missouri, into Eurofins Viracor BioPharma’s purpose‑built, eleven‑acre facility in Lenexa, Kansas. The bioanalytical organization brings more than two decades of specialized experience in pharmacokinetics, immunogenicity, and biomarker testing. By combining both laboratories’ strengths, Eurofins V

HKTDC to Host World’s Largest One-Stop Jewellery Marketplace9.2.2026 12:37:00 EET | Press release

Organised by the Hong Kong Trade Development Council (HKTDC), the world’s largest one‑stop jewellery marketplace will return in early March under its proven “Two Shows, Two Venues” format. The 12th Hong Kong International Diamond, Gem & Pearl Show will take place from 2 to 6 March at AsiaWorld‑Expo, featuring a wide range of jewellery raw materials. Also, the 42nd Hong Kong International Jewellery Show will be held from 4 to 8 March at the Hong Kong Convention and Exhibition Centre, showcasing finished jewellery pieces. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260207153040/en/ Hong Kong International Jewellery Show and Hong Kong International Diamond, Gem & Pearl Show Jenny Koo, Deputy Executive Director of the HKTDC, said: “This year’s twin jewellery shows bring together some 4,000 exhibitors from over 40 countries and regions, with nearly 70% coming from outside Hong Kong. The HKTDC presents the world’s largest one-s

FlexTrade Integrates CME Group’s FX Spot+ and EBS Market Offerings for Enhanced FX Trading9.2.2026 12:30:00 EET | Press release

FlexTrade Systems(@FlexTrade), a global leader in multi-asset execution and order management systems, today announced an integration with CME Group’s EBS Market central limit order book (CLOB) and its FX Spot+ platform.The move is designed to diversify and deepen the sources of actionable liquidity available to FlexTrade’s FlexFX users through an integration into CME Group's substantial liquidity pools for spots via FX Spot+. Providing firm, anonymous liquidity and no last-look pricing, EBS Market is a venue for both large market participants in search of FX liquidity in an all-to-all CLOB, and for market-making banks hedging FX risk. FX Spot+ further enhances spot liquidity with Futures liquidity from CME Group. This partnership is integral in helping firms further expand FX liquidity and take advantage of global opportunity. Mutual clients of FlexTrade and CME Group can integrate FX Spot+ and EBS Market liquidity into their existing FlexFX workflows, accelerating time to market and r

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye